Mariam Aboian's background training and clinical experience is focused on neuroimaging of primary brain tumors and metastatic cancer to the brain, with dedicated subspecialty training in neuroradiology and nuclear medicine. The focus of her research is to identify imaging biomarkers that predict tumor type, tumor molecular signature, and patient outcomes in adult and pediatric brain tumors. To achieve this, she uses a multimodal approach to study brain cancer, including MRI, radiomics, molecular imaging with positron emission tomography (PET), and hybrid PET/MRI.